New Delhi: Krsnaa Diagnostics Limited has entered into a strategic partnership with Medikabazaar India and United Imaging. This collaboration is poised to disrupt the industry with a ₹300+ Crore investment, targeting the establishment of over 30+ cutting-edge imaging centers across Tier-2 and Tier-3 cities across India.
This partnership, which is one of the largest of its kind in the Indian diagnostics space, brings together the best of technology and healthcare expertise to significantly enhance patient care and accessibility. Aiming to bridge the gap in diagnostics in small towns and semi-urban areas, the collaboration will provide increased focus on advanced Radiology Imaging solutions by reaching the communities most in need, thus enhancing overall patient care to the masses.
“We are thrilled to join hands with Medikabazaar and United imaging in what we see as a transformative alliance for the Indian diagnostics industry,” said Rajendra Mutha, Chairman of Krsnaa Diagnostics. “This collaboration not only enables us to expand our footprint into under-served regions but also strengthens our ability to offer cutting-edge imaging services at competitive prices. The special terms provided by United Imaging structured by Medikabazaar speak volumes about the trust they place in our operational excellence and leadership in the sector.”
Speaking on the significance of the collaboration, Dinesh Lodha, Group CEO, Medikabazaar, commented, “This collaboration brings together India’s two largest entities in the medical supplies and the diagnostics space and will revolutionize healthcare accessibility, ensuring timely diagnosis and affordable advanced healthcare for under-served populations. It aligns with the country’s healthcare targets and aims to promote better infrastructure and healthcare delivery, especially in under-developed and under-served regions.”
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans